Is there an Indian version of Selumetinib?

It is understood that there is no Indian version of Selumetinib (Selumetinib) original drug or generic drug produced and sold. Selumetinib is an oral selective inhibitor of MEK 1 and 2 that has shown activity against several advanced adult cancers. Selumetinib 's Phase 1 trial results and preclinical data on the activity of selumetinib in animal models of neurofibromatosis indicate neurofibromatosis type 1 (NF1) in pediatric patients with symptomatic, inoperable plexiform neurofibromas (PN).

Neurofibromatosis may cause tumors in the brain or spinal cord, learning disabilities, tumors on or under the skin, or bone deformities. Plexiform neurofibromas are large tumors that grow from nerves anywhere in the body and can become cancerous later in life. Indeed, one study investigating the effects of selumetinib in children with NF-1 found a reduction in tumor size following treatment with the antineoplastic drug, and also subjectively reported a reduction in tumor-related pain and an improvement in overall function. Selumetinib has minimal off-target activity and therefore has an impressive safety profile.

SelumetinibThe original drug has been launched in China, but it has not yet entered the scope of medical insurance. SpecificationThe price of 10mg*60 tablets per box may be more than 20,000 yuan, which is relatively expensive. SelumetinibOriginal drug marketed overseas, the price of 10mg*60 pills per box may be more than 50,000 yuan, and the price of 25mg*60 pills per box may be 1 More than RMB 00,000 (the price may fluctuate due to the exchange rate). The ingredients of the original version of selumetinib sold at home and abroad are basically the same. There is currently no generic version of selumetinib on the market. For more drug information and specific prices, please consult Yaode Medical Consultants.